Kim Stratton

Kim Stratton

Director/Board Member at RECORDATI
64 year
Health Technology
Process Industries
Commercial Services

Profile

Kim Stratton is currently a Non-Executive Director at Recordati SpA since 2021, a Director at the European Federation of Pharmaceutical Industries & Assns, a Director at Vifor Pharma Management AG, and an Independent Director at Novonesis (Novozymes A) starting in 2024.
Former roles include Chief Executive Officer at Strategic Partners A from 2019 to 2020, Chief Executive Officer & Managing Director at Centogene NV from 2021 to 2023, Chief Executive Officer at Centogene GmbH, Independent Director at Corden Pharma Fribourg SA, Independent Director at Novozymes A from 2017 to 2023, Head-Marketing at Bristol Myers Squibb Co., Head-United Kingdom Respiratory Business at AstraZeneca PLC, Head-Group Country Management & External Affairs at Novartis AG from 2010 to 2013, Sales Representative at GlaxoSmithKline Investments Pty Ltd., Chief Operating Officer at Novartis UK Ltd., and Head-International Commercial at Shire International GmbH.

Kim Stratton active positions

CompaniesPositionStart
RECORDATI Director/Board Member 16/12/2021
Director/Board Member -
Director/Board Member -

Former positions of Kim Stratton

CompaniesPositionEnd
STRATEGIC PARTNERS A/S Chief Executive Officer 10/12/2020
NOVARTIS AG Public Communications Contact 01/03/2013
Chief Executive Officer -
CENTOGENE N.V. Chief Executive Officer -
Chief Operating Officer -
See the detail of Kim Stratton's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

78

1st degree connections

14

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies14

Health Technology

Health Technology

Process Industries

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Distribution Services

Health Technology

Health Services